Details of the Drug
General Information of Drug (ID: DMCIJU0)
| Drug Name |
N-Benzyl-4-Sulfamoyl-Benzamide
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
n-benzyl-4-sulfamoyl-benzamide; N-benzyl-4-sulfamoylbenzamide; CHEMBL302715; 107619-27-2; Benzamide, 4-(aminosulfonyl)-N-(phenylmethyl)-; 1g4o; ACMC-20mb2s; AC1L1HYJ; SCHEMBL678390; 4-Sulfamoyl-N-benzylbenzamide; CTK0D6518; BDBM12013; DTXSID80274429; MolPort-004-614-705; ZINC403946; HMS3604F04; AKOS001408419; MCULE-1382374853; DB01748; 4-(AMINOSULFONYL)-N-PHENYLMETHYLBENZAMIDE
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 290.34 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 0.8 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||


